Articles
6939 result(s) for 'sepsis' within Critical Care
Page 17 of 139
-
Citation: Critical Care 2002 6(Suppl 1):P77
-
The effects of N-acetylcysteine on the levels of glutathione, serum TNFα, and tissue malondialdehyde in sepsis
Citation: Critical Care 2007 11(Suppl 2):P9 -
Lung-protective ventilation suppresses plasma levels of cell-free DNA in porcine experimental postoperative sepsis
Citation: Critical Care 2014 18(Suppl 1):P292 -
Procalcitonin as prognostic marker in severe sepsis of abdominal origin
Citation: Critical Care 2015 19(Suppl 1):P58 -
Challenges to implementation of sepsis guidelines
Citation: Critical Care 2009 13(Suppl 4):P29 -
Study of procalcitonin as a marker of sepsis in patients of a general hospital during a 2-year period
Citation: Critical Care 2007 11(Suppl 4):P29 -
Effect of organ failure on outcomes in neutropenic sepsis
Citation: Critical Care 2011 15(Suppl 1):P288 -
Use of CD64 for the diagnosis of sepsis: a case-control study
Citation: Critical Care 2010 14(Suppl 1):P32 -
Comparison between left ventricular tissue Doppler strain imaging and the sequential organ failure assessment score (SOFA score) in patients with severe sepsis or septic shock
Citation: Critical Care 2010 14(Suppl 1):P390 -
Antibacterial therapy in treatment of newborns with perinatal sepsis
Citation: Critical Care 2012 16(Suppl 3):P112 -
The incidence of serious bleeding events in a global, single-arm, open-label trial of Drotrecogin alfa (activated) in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
Citation: Critical Care 2004 8(Suppl 1):P116 -
Outcomes in urinary sepsis
Citation: Critical Care 2013 17(Suppl 2):P44 -
Activity of GH/IGF-I axis in catabolic patients with sepsis or trauma
Citation: Critical Care 1997 1(Suppl 1):P101 -
Validation of the APACHE IV scoring system in patients with severe sepsis and comparison with the APACHE II system
Citation: Critical Care 2009 13(Suppl 1):P511 -
Role of central nitric oxide on hormonal and cardiovascular alterations in experimental polymicrobial sepsis
Citation: Critical Care 2008 12(Suppl 5):P33 -
suPARnostic® as a treatment efficacy monitoring tool in systemic inflammatory response syndrome/sepsis patients
Citation: Critical Care 2008 12(Suppl 5):P37 -
High impact of Sepsis-related Organ Failure Assessment score on mortality prediction of patients undergoing valve replacement on the first postoperative day
Citation: Critical Care 2003 7(Suppl 3):P100 -
Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients
Citation: Critical Care 2004 8(Suppl 1):P187 -
TIMP-1, TIMP-2 and MMP-9 as prognostic markers for clinical outcome in sepsis
Citation: Critical Care 2003 7(Suppl 2):P033 -
Burden of mortality related to sepsis in Brazil from 2002 to 2011
Citation: Critical Care 2013 17(Suppl 4):P65 -
Peaks in G-CSF serum concentrations are accompanied by an increase in phagocytotic activity in most patients with severe sepsis or septic shock
Citation: Critical Care 2001 5(Suppl 1):P067 -
Comparing Gray's and Cox models in sepsis survival
Citation: Critical Care 2001 5(Suppl 1):P248 -
Bacterial translocation consequential to intestinal bacterial overgrowth provokes aggravation of mortality by sepsis
Citation: Critical Care 2003 7(Suppl 3):P28 -
Value of Tc-99m DMSA renal scan in assessing the prognosis and outcome of acute renal failure due to sepsis
Citation: Critical Care 2013 17(Suppl 2):P417 -
Survey of severe sepsis and septic shock management in Thailand: THAI-SHOCK SURVEY 2013
Citation: Critical Care 2014 18(Suppl 1):P80 -
Prognostic value of raised procalcitonin when combined with routine biomarkers of sepsis among critically ill patients
Citation: Critical Care 2008 12(Suppl 2):P184 -
Influence of hydroxyethyl starch and gelatin versus crystalloids on renal function, fluid balance, and ICU length of stay in patients with severe sepsis
Citation: Critical Care 2010 14(Suppl 2):P39 -
A post-authorisation survey to analyse the perioperative teicoplanin plasma concentrations in adult patients with chronic bone sepsis, who received loading doses of 12 mg/kg 12-hourly for 48 hours followed by 12 mg/kg once daily
Citation: Critical Care 2012 16(Suppl 1):P69 -
Triiodothyronine (T3) ameliorates the cytokine storm in rats with sepsis
Citation: Critical Care 2000 4(Suppl 1):P59 -
Ceftazidime reduces pulmonary hypertension in an ovine model of sepsis following smoke inhalation injury
Citation: Critical Care 2005 9(Suppl 1):P36 -
A standardized protocol for the multiplex PCR technique Septifast® Roche for neonatal samples with suspected sepsis
Citation: Critical Care 2012 16(Suppl 3):P79 -
Treatment of acute respiratory distress syndrome using the recommendations of the Brazilian Consensus of Sepsis in an ICU of a teaching hospital
Citation: Critical Care 2005 9(Suppl 2):P92 -
Mortality-associated factors in old patients with severe sepsis or septic shock in the medical intensive care unit
Citation: Critical Care 2007 11(Suppl 3):P29 -
Acute effect of low-dose corticosteroids on muscle function in patients with severe sepsis and septic shock
Citation: Critical Care 2009 13(Suppl 3):P15 -
Pulse pressure variability as a predictor of volume responsiveness in patients with sepsis
Citation: Critical Care 2000 2:5959 -
Outcome and cost of sepsis in intensive care units in Hungary
Citation: Critical Care 2003 7(Suppl 2):P231 -
De-escalation of antimicrobial therapy in Gram-negative sepsis: easier said than done?
Citation: Critical Care 2011 15(Suppl 1):P219 -
sTREM-1 is not suitable to discriminate survivors and nonsurvivors in surgical patients with severe sepsis or septic shock
Citation: Critical Care 2007 11(Suppl 2):P47 -
Fluid therapy change from synthetic colloids to only crystalloids in patients with severe sepsis
Citation: Critical Care 2010 14(Suppl 1):P500 -
The biphasic aPTT waveform to diagnose sepsis in patients with systemic inflammatory response syndrome
Citation: Critical Care 2007 11(Suppl 2):P51 -
Effects of solid dispersion of curcumin in metabolic and immunological alterations during experimental sepsis
Citation: Critical Care 2013 17(Suppl 4):P100 -
Gene expression in sepsis is independent of the center-associated effects and indicates a tight regulation of the inflammatory process
Citation: Critical Care 2006 10(Suppl 1):P92 -
The extent and effect of sepsis in the first 24-hours of intensive care in one country
Citation: Critical Care 2002 6(Suppl 1):P242 -
Optimal hemodynamic management according to the Surviving Sepsis Guidelines is not applicable to all ICU patients
Citation: Critical Care 2008 12(Suppl 2):P398 -
Use of milrinone in non-hyperdynamic sepsis
Citation: Critical Care 1999 2:1362 -
Caspase-1 and ASC but not NLRP3 mediate antifungal defense in candidiasis sepsis
Citation: Critical Care 2009 13(Suppl 4):P31 -
Immature platelet fraction as predictive index of sepsis
Citation: Critical Care 2010 14(Suppl 1):P34 -
Examination of the diagnostic accuracy of sepsis using procalcitonin, presepsin and CD64 for patients with or without acute kidney injury
Citation: Critical Care 2015 19(Suppl 1):P64 -
Frequency and clinical spectrum of myocardial dysfunction in severe sepsis and septic shock
Citation: Critical Care 2010 14(Suppl 1):P392 -
Sustained high-efficiency daily diafiltration using a cytokine-adsorbing membrane in the treatment of patients with severe sepsis
Citation: Critical Care 2011 15(Suppl 1):P115
Follow
- ISSN: 1364-8535 (electronic)